Cargando…
Potassium binders for patients with heart failure? The real enlightenment of the DIAMOND trial( )
[Figure: see text]
Autor principal: | Packer, Milton |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622298/ https://www.ncbi.nlm.nih.gov/pubmed/35900836 http://dx.doi.org/10.1093/eurheartj/ehac399 |
Ejemplares similares
-
Experience with the potassium binder patiromer in hyperkalaemia management in heart failure patients in real life
por: Esteban‐Fernández, Alberto, et al.
Publicado: (2022) -
Optimizing Therapies in Heart Failure: The Role of Potassium Binders
por: Scicchitano, Pietro, et al.
Publicado: (2022) -
Potassium binders for the prevention of hyperkalaemia in heart failure patients: implementation issues and future developments
por: Zannad, Faiez, et al.
Publicado: (2019) -
Optimization of RAASi Therapy with New Potassium Binders for Patients with Heart Failure and Hyperkalemia: Rapid Review and Meta-Analysis
por: Montagnani, Andrea, et al.
Publicado: (2021) -
Empagliflozin and serum potassium in heart failure: an analysis from
EMPEROR-Pooled( )
por: Ferreira, João Pedro, et al.
Publicado: (2022)